SHANGHAI FUDAN-ZHANGJIANG BIO-PHARMACEUTICAL CO.LTD financial statements, including revenue, expenses, profit, and loss

The total revenue of 688505 for the last quarter is 146.38 M CNY, and it's 3.61% higher compared to the previous quarter. The net income of Q1 24 is 2.35 M CNY.